Metys Pharmaceuticals
Stop Cancer Patients from Stopping Treatment
Dimiracetam, a transformative therapy for the acute sensory neuropathy caused by chemotherapy.
metys-pharma.ch
Program·Poster exhibitions
Let your project speak for itself, all conference long.
About the format
Poster exhibitions offer Swiss R&D biotech companies an excellent opportunity to showcase their research, innovation and value proposition to a global audience of investors, pharma partners and talent.
Attendees explore the posters throughout the conference. Posters support outreach and scouting for the whole two days, and during the two dedicated poster sessions company representatives are available at their posters to discuss their work.

Why take part
Present your value proposition and latest business developments to the people who scout for them.
Two dedicated sessions bring genuinely interested attendees to your poster.
Initiate partnerships, collaborations or investment discussions at an early stage.
Swiss innovation spotlight
Swiss biotech companies present their research, pipeline and partnering opportunities as posters, on display for the whole conference and discussed in two 45-minute poster sessions. A couple of examples from the 2026 series, with a link to each company.
Read the poster
Metys Pharmaceuticals
Dimiracetam, a transformative therapy for the acute sensory neuropathy caused by chemotherapy.
metys-pharma.ch
Read the poster
Onward Therapeutics
Bispecific antibodies, an allogeneic NK cell therapy and small molecules to overcome resistance in cancer care.
onward-therapeutics.com
Read the poster
Synendos Therapeutics
A phase 2 clinical-stage company using first-in-class selective endocannabinoid reuptake inhibitors to restore function in neuropsychiatric patients.
synendos.comHelp showcase the full strength of the Swiss biotech ecosystem with your poster at the Swiss Biotech Day.
Program